Ruwe Data Online Survey

Medication Review Type 2a (MR2a) has been reimbursed in Belgium since April 2023. To assess its adoption and the willingness to implement this service, an online questionnaire was developed, consisting of multiple-choice questions, Likert Scale questions and open-ended questions was developed to see the adoption and the willingness to implement this service. A total of 1280 participants were registered for this online survey, of which only those who answered more than 50% of the questions were included in the analysis.Further details in upcoming paper.